QS Investors’s Surmodics SRDX Stock Holding History

QS Investors’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$353K	Hold	6,500	–	–	﹤0.01%	881
2021 Q1	$365K	Hold	6,500	–	–	﹤0.01%	911
2020 Q4	$283K	Buy	6,500 +200	+3%	+$7.87K	﹤0.01%	1014
2020 Q3	$246K	Sell	6,300 -40,950	-87%	-$1.8M	﹤0.01%	1002
2020 Q2	$2.04M	Hold	47,250	–	–	0.03%	479
2020 Q1	$1.57M	Sell	47,250 -200	-0.4%	-$7.22K	0.03%	506
2019 Q4	$1.94M	Sell	47,450 -475	-1%	-$20K	0.02%	601
2019 Q3	$2.19M	Hold	47,925	–	–	0.02%	535
2019 Q2	$2.07M	Sell	47,925 -775	-2%	-$32.7K	0.02%	579
2019 Q1	$2.12M	Buy	48,700 +16,000	+49%	+$815K	0.02%	584
2018 Q4	$1.55M	Buy	+32,700	New	+$1.96M	0.02%	648
2013 Q3	–	Sell	-18,300	Closed	-$366K	–	651
2013 Q2	$366K	Buy	+18,300	New	+$458K	0.01%	562

Other funds holding SRDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

QS Investors's SRDX Position: Q2 2021 in Review

QS Investors held its Surmodics (SRDX) position steady in Q2 2021 at 6,500 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #881.

QS Investors first reported a position in SRDX in Q2 2013 and has held it in 12 quarters since. The position peaked at $2.19M in Q3 2019. 147 funds tracked by Wall St. Rank hold SRDX as of Q2 2021.

QS Investors held 6,500 shares of Surmodics worth $353K as of Q2 2021.
QS Investors left its Surmodics share count unchanged in Q2 2021.
Surmodics made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #881 holding.
QS Investors first reported a position in Surmodics in Q2 2013 and has held it in 12 quarters since.
QS Investors's Surmodics position peaked at $2.19M in Q3 2019.
147 funds tracked by Wall St. Rank held Surmodics as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.